Chinese venture capital (VC) firm Addor Capital announced on Tuesday the completion of its second health industry investment fund at 1.557 billion yuan ($240.8 million) to step up investments in emerging innovative drug developers in the country.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
